CAP2
Basic information
Region (hg38): 6:17393595-17557780
Links
Phenotypes
GenCC
Source:
- familial isolated dilated cardiomyopathy (Supportive), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cardiomyopathy, dilated, 2I | AR | Cardiovascular | The condition can involve structural cardiac anomalies, arrhthymias, and congestive heart failure, and awanress may be beneficial realed to medical management; Cardiac transplant has been described | Cardiovascular; Musculoskeletal | 30518548; 33083013; 34862840 |
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the CAP2 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 27 | 29 | ||||
nonsense | 0 | |||||
start loss | 1 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 1 | ||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 2 | 1 |
Variants in CAP2
This is a list of pathogenic ClinVar variants found in the CAP2 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
6-17421557-T-C | Cardiomyopathy, dilated, 2I | Uncertain significance (Nov 07, 2021) | ||
6-17421593-G-A | Cardiomyopathy, dilated, 2I | Uncertain significance (Jun 07, 2021) | ||
6-17421605-G-A | not specified • Cardiomyopathy, dilated, 2I | Uncertain significance (Nov 28, 2023) | ||
6-17421614-C-T | not specified | Likely benign (Aug 21, 2023) | ||
6-17421641-C-A | CAP2-associated dilated cardiomyopathy | Uncertain significance (May 21, 2021) | ||
6-17421665-G-A | not specified | Uncertain significance (Jan 03, 2024) | ||
6-17426592-G-A | not specified | Uncertain significance (Dec 07, 2023) | ||
6-17426623-T-C | Uncertain significance (Sep 09, 2022) | |||
6-17426627-G-A | not specified | Uncertain significance (Feb 17, 2024) | ||
6-17426679-G-T | not specified | Uncertain significance (Nov 03, 2022) | ||
6-17507218-T-A | not specified | Uncertain significance (Dec 01, 2022) | ||
6-17507241-C-T | not specified | Uncertain significance (Apr 25, 2023) | ||
6-17507269-C-T | not specified | Uncertain significance (Apr 22, 2022) | ||
6-17507274-G-A | Uncertain significance (Mar 11, 2022) | |||
6-17507310-G-C | not specified | Uncertain significance (Mar 23, 2022) | ||
6-17507311-T-C | not specified | Uncertain significance (May 17, 2023) | ||
6-17507680-G-A | not specified | Uncertain significance (Nov 18, 2022) | ||
6-17507704-G-A | not specified | Uncertain significance (Dec 13, 2022) | ||
6-17513857-G-C | not specified | Uncertain significance (Mar 19, 2024) | ||
6-17513926-A-G | Uncertain significance (Feb 23, 2024) | |||
6-17513932-C-T | not specified | Uncertain significance (Jan 23, 2024) | ||
6-17539287-G-A | not specified | Uncertain significance (Mar 11, 2022) | ||
6-17539335-C-G | not specified | Uncertain significance (May 20, 2024) | ||
6-17539383-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
6-17539410-C-T | not specified | Uncertain significance (Dec 14, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
CAP2 | protein_coding | protein_coding | ENST00000229922 | 12 | 164577 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.699 | 0.301 | 125733 | 0 | 13 | 125746 | 0.0000517 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.10 | 221 | 272 | 0.812 | 0.0000145 | 3141 |
Missense in Polyphen | 77 | 119.43 | 0.64474 | 1408 | ||
Synonymous | 0.532 | 93 | 99.8 | 0.932 | 0.00000589 | 906 |
Loss of Function | 3.80 | 5 | 25.9 | 0.193 | 0.00000119 | 305 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000123 | 0.000123 |
Ashkenazi Jewish | 0.0000992 | 0.0000992 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000887 | 0.0000879 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May have a regulatory bifunctional role.;
- Pathway
- Ectoderm Differentiation;Aryl Hydrocarbon Receptor Pathway;Nuclear Receptors Meta-Pathway;Developmental Biology;Signaling by ROBO receptors;Axon guidance;Role of ABL in ROBO-SLIT signaling
(Consensus)
Recessive Scores
- pRec
- 0.105
Intolerance Scores
- loftool
- 0.312
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 50.22
Haploinsufficiency Scores
- pHI
- 0.323
- hipred
- Y
- hipred_score
- 0.500
- ghis
- 0.524
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0194
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Cap2
- Phenotype
- cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); immune system phenotype; vision/eye phenotype; muscle phenotype; limbs/digits/tail phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype;
Zebrafish Information Network
- Gene name
- cap2
- Affected structure
- whole organism
- Phenotype tag
- abnormal
- Phenotype quality
- decreased length
Gene ontology
- Biological process
- cell morphogenesis;establishment or maintenance of cell polarity;signal transduction;activation of adenylate cyclase activity;actin polymerization or depolymerization
- Cellular component
- plasma membrane;postsynaptic density;cortical actin cytoskeleton
- Molecular function
- actin binding;protein binding;adenylate cyclase binding;identical protein binding